IBD 50 stocks have outperformed since a new rally was confirmed on May 14. Since then the IBD 50 has gained 2.6%, while the Nasdaq is up just 0.4%. Despite the outperformance, just a handful of breakouts since the follow-through day have produced decent gains. Skyworks Solutions (SWKS), Avago Technologies (AVGO), Synaptics (SYNA), Regeneron Pharmaceuticals (REGN) and Papa John’s (PZZA) have each climbed 4% to 9% past recent buy points.